Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity via Maintaining Mitochondrial Homeostasis

Shenmai injection (SMI), as a patented traditional Chinese medicine, is extracted from Panax ginseng and Ophiopogon japonicus. It commonly used in the treatment of cardiovascular disease and in the control of cardiac toxicity induced by doxorubicin (DOX) treatment. However, its anti-cardiotoxicity m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Li, Lin, Li, Jinghao, Wang, Qilong, Zhao, Xin, Yang, Dongli, Niu, Lu, Yang, Yanze, Zheng, Xianxian, Hu, Limin, Li, Yuhong
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7289952/
https://ncbi.nlm.nih.gov/pubmed/32581790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00815
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars